Sugarloaf Wealth Management, LLC Alaunos Therapeutics, Inc. Transaction History

Sugarloaf Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	SELL	$0.04 - $0.13 $400 - $1,300	-10,000 Reduced 13.25%	65,500 $4,000
Q1 2023 Apr 26, 2023	BUY	$0.46 - $0.81 $2,300 - $4,050	5,000 Added 7.09%	75,500 $47,000
Q4 2022 Feb 03, 2023	SELL	$0.5 - $261.0 $4,275 - $2.23 Million	-8,550 Reduced 10.82%	70,500 $45,000
Q3 2022 Oct 11, 2022	BUY	$1.04 - $322.5 $2,600 - $806,250	2,500 Added 3.27%	79,050 $136,000
Q2 2022 Jul 12, 2022	BUY	$0.41 - $1.24 $31,385 - $94,922	76,550 New	76,550 $95,000
Q1 2022 Apr 25, 2022	SELL	$0.62 - $1.17 $39,711 - $74,938	-64,050 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$1.09 - $1.89 $32,482 - $56,322	29,800 Added 87.01%	64,050 $70,000
Q2 2021 Jul 20, 2021	BUY	$2.63 - $3.67 $26,300 - $36,700	10,000 Added 41.24%	34,250 $90,000
Q4 2019 Jan 29, 2020	BUY	$3.95 - $5.35 $95,787 - $129,737	24,250 New	24,250 $114,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.